Themis Medicare Limited (NSE:THEMISMED)
168.20
+17.10 (11.32%)
May 19, 2025, 3:29 PM IST
Themis Medicare Company Description
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally.
The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics.
It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001.
Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai, India.
Themis Medicare Limited

Country | India |
Founded | 1952 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 1,509 |
CEO | Sachin Patel |
Contact Details
Address: 11/12 Udyog Nagar Industrial Estate Mumbai, Maharashtra 400104 India | |
Phone | 91 22 6760 7080 |
Website | themismedicare.com |
Stock Details
Ticker Symbol | THEMISMED |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
ISIN Number | INE083B01024 |
SIC Code | 5912 |
Key Executives
Name | Position |
---|---|
Dr. Sachin Dinesh Patel CChem., Ph.D. | Chief Executive Officer, MD and Executive Director |
Dr. Dinesh Shantilal Patel CChem., FRSC(Lond.), Ph.D. | Executive Chairman |
Reena Sachin Patel | Vice President of Systems and Administration and Alternate Non-Executive Non-Independent Director |
Tushar J. Dalal A.C.A. | Chief Financial Officer |
Pradeep Manjunath Chandan | Company Secretary and Compliance Officer |